Latest filing published 16 Oct 2017 for PFIZER INC, €49k.
Filing timeline
BuySaleInsider track record
Closed purchases
Not enough history yet: 1 closed purchase, at least 2 are needed.
Purchases by company
Since each purchase
- +23.1%Entry US$34.35 · Close at T+365 US$42.29
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
James C. Smith: trading record in brief
All filings by James C. Smith on record concern Pfizer Inc. In total, 2 filings cover trades dated from 20 December 2016 to 28 December 2016.
The open-market side counts 1 purchase for €49k alongside 1 sale for €743. The net balance comes to €49k on the buying side. A purchase on the market is a deliberate choice to commit personal money, which is why it draws more attention than a grant. In 2017 alone, the filings show 1 purchase and 1 sale.
The latest filing, published on 16 October 2017, reports an open-market purchase of €49k in Pfizer Inc. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to James C. Smith
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 1,566 shares@ US$32.8498.5% of flowCommon StockSEC:0001225208-17-016284:0Canonical exit: 20 Mar 2017 (T+90)
- 24 shares@ US$32.381.5% of flowCommon StockSEC:0001225208-17-016284:1
2 of 2 declarations
